Rajesh K Sinha

Requesting 4 Candid Feedback : 💊 The Business of Conferences (India’s total CME market at ≈ $1.6 billion (~₹13,280 crore) in Indian – Boon, Bane, or Both? Dark Currency to White ? Every year, the Indian pharmaceutical industry spends crores of rupees sponsoring, organising, and attending high-profile doctor conferences — from ANCIPS, MediConclave, APICON, AIOC, PEDICON, IOACON, FOGSI Annual Conference, to CardioCon, DermaCon, and many more. What Really Happens at These Conferences? For Doctors 🩺 . Barring a few committed academicians who deliver lectures, present research papers, and share genuine scientific updates with slides, a large portion of attendees treat the event as… well… a networking getaway. . For many, it’s about meeting peers, exploring the exhibition stalls, and yes, enjoying the gala dinners, wines & cultural nights. . In between sessions, there’s often a mix of catching up with old friends and meeting new company representatives. For Senior Pharma Managers 👔 . Zonal, Regional, and National Heads attend to ensure their company’s visibility is maximised. . They meet key doctors, negotiate future business opportunities, and build relationships over coffee tables or banquet dinners. . Many also supervise the execution of sponsorship commitments — from ensuring the brand logo is visible on banners, to making sure the sponsored symposium runs as planned. For MRs, ASMs, and RSMs 🚶‍♂️ . Medical Representatives (MRs) usually manage stall activity, greet doctors, and distribute literature or samples. . Area Sales Managers (ASMs) coordinate the flow of visiting doctors, handle last-minute arrangements, and act as a bridge between field teams and the head office. . Regional Sales Managers (RSMs) often focus on higher-value relationship building — escorting key opinion leaders (KOLs) to sponsored events, facilitating introductions, and ensuring smooth logistics for VIP doctors. Pros of Conferences ✅ . Knowledge Sharing: Platform for genuine academic exchange (when it happens sincerely). . Relationship Building: Helps pharma teams strengthen trust with key doctors. . Brand Visibility: Strategic placements and sponsorships enhance recall. Networking: Facilitates doctor-to-doctor and doctor-to-pharma connections. Cons of Conferences ❌ . High Cost, Questionable ROI: Sponsorships run into lakhs or crores, but measurable returns are often vague. . Distraction from Core Purpose: Entertainment sometimes overshadows academic goals. . Overcrowded Branding: With dozens of companies vying for attention, differentiation is tough. . Fatigue Factor: Doctors & pharma teams attend multiple such events a year, reducing the novelty. The Bigger Question 🤔 💬 I’d love to hear from doctors, MRs, managers, and conference organisers — What’s your take on the real value of these conferences? #IndianPharma #PharmaMarketing #MedicalConferences #ANCIPS #APICON #FOGSI #CardioCon #Dermacon #PharmaIndustry #DoctorEngagement #PharmaSales #HealthcareMarketing

74

21 Comments

𝐑𝐚𝐡𝐮𝐥 𝐒𝐢𝐧𝐠𝐡 𝐑𝐚𝐣𝐩𝐮𝐭 𝐀𝐩𝐩𝐨𝐢𝐧𝐭𝐞𝐝 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 𝐚𝐭 𝐌𝐀𝐂𝐋𝐄𝐎𝐃𝐒 𝐏𝐇𝐀𝐑𝐌𝐀𝐂𝐄𝐔𝐓𝐈𝐂𝐀𝐋𝐒 𝐋𝐓𝐃. MACLEODS PHARMACEUTICALS LTD. has appointed Rahul Singh as 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐌𝐚𝐧𝐚𝐠𝐞𝐫, signaling a strong focus on execution-led leadership in one of India’s most competitive pharmaceutical markets. In an industry where success is built through consistent field performance, hospital engagement, and last-mile execution, elevation reflects a shift from transactional sales management to enterprise-level commercial leadership. This role is less about titles and more about scale--turning regional strength into sustained market impact. With over 15 years of experience across Torrent Pharmaceuticals Ltd ,Dr. Reddy's Laboratories, MANKIND PHARMA LTD , and MACLEODS PHARMACEUTICALS LTD. , Rahul brings deep, on-ground understanding of diverse therapy areas, market structures, and go-to-market models. His career has been shaped where pharma growth truly happens: in clinics, hospitals, and customer-facing execution. Prior to this appointment, Rahul served as 𝐒𝐞𝐧𝐢𝐨𝐫 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 at MACLEODS PHARMACEUTICALS LTD. leading regional sales operations across Gujarat. His responsibilities spanned driving market share in key therapy segments, managing strategic hospital and institutional accounts, building high-performing sales teams, and strengthening distributor and channel partnerships. His leadership consistently combined execution discipline with relationship-driven growth. MACLEODS PHARMACEUTICALS LTD. operates in a highly dynamic environment defined by intense competition, frequent product launches, rising expectations from healthcare professionals, and increasing reliance on data-driven sales models. Rahul’s appointment brings forward a leadership profile well-suited to these demands-grounded in market intelligence, team leadership, and execution credibility. As 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐌𝐚𝐧𝐚𝐠𝐞𝐫, his focus is expected to include scaling regional success, strengthening key account partnerships, developing next-generation sales leaders, and building commercial systems that deliver sustainable growth. Rahul’s journey represents a new generation of pharma leadership-where strategy is informed by ground reality, and growth is built from the field upward. At CXO Gateway, we celebrate Rahul Singh Rajput’s appointment as a strong example of frontline execution evolving into strategic leadership. This move reinforces the reality that in Indian pharma, sustainable growth is built by leaders who understand the market from the ground up. 🔗 Read more about his journey & appointment on https://lnkd.in/gKzpTq5X

21

1 Comment

📢 CDSCO Regulatory Update | June 2026 The Indian pharmaceutical industry continues to evolve with stronger regulatory oversight and global alignment. 🔹 Key CDSCO Updates: ✅ Revision of testing fees under Schedule B & B1 ✅ Inclusion of Pregabalin under Schedule H1 regulations ✅ Revised guidelines for sampling of Drugs, Cosmetics & Medical Devices ✅ Strengthened pharmacovigilance with updated PSUR submission requirements via SUGAM Portal ✅ Faster drug testing approvals through immediate NOC issuance for laboratory testing These initiatives reflect CDSCO’s commitment to enhancing quality, patient safety, and regulatory efficiency while aligning Indian pharma with global standards. As an industry, staying compliant and proactive is essential to drive innovation and build trust in healthcare. #CDSCO #PharmaIndustry #RegulatoryAffairs #QualityCompliance #Pharmaceuticals #DrugRegulation #GMP #SUGAM #Healthcare #IndiaPharma

10